Zentalis Pharmaceuticals, Inc. (ZNTL)
 NASDAQ: ZNTL · Real-Time Price · USD
 1.485
 -0.045 (-2.94%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Analyst Ratings
Total Analysts  
 6
Consensus Rating  
 Buy
Price Target  
 $6.53
Upside  
 +339.73%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date | 
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +236.70% | Aug 7, 2025 | 
| Wedbush | Wedbush | Hold Reiterates $4 | Hold | Reiterates | $4 | +169.36% | May 15, 2025 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +573.40% | May 15, 2025 | 
| Wedbush | Wedbush | Hold Reiterates $4 | Hold | Reiterates | $4 | +169.36% | Mar 28, 2025 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +573.40% | Mar 27, 2025 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +573.40% | Mar 17, 2025 | 
| Wells Fargo | Wells Fargo | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +304.04% | Jan 30, 2025 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $10 | Strong Buy | Maintains | $20 → $10 | +573.40% | Jan 29, 2025 | 
| UBS | UBS | Hold Maintains $5 → $2.2 | Hold | Maintains | $5 → $2.2 | +48.15% | Jan 28, 2025 | 
| Guggenheim | Guggenheim | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +438.72% | Nov 15, 2024 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,246.80% | Nov 15, 2024 | 
| Oppenheimer | Oppenheimer | Buy Reiterates $20 | Buy | Reiterates | $20 | +1,246.80% | Sep 16, 2024 | 
| Wedbush | Wedbush | Sell → Hold Upgrades $4 | Sell → Hold | Upgrades | $4 | +169.36% | Aug 12, 2024 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,246.80% | Aug 12, 2024 | 
| UBS | UBS | Strong Buy → Hold Downgrades $28 → $5 | Strong Buy → Hold | Downgrades | $28 → $5 | +236.70% | Jun 20, 2024 | 
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $29 → $9 | Buy → Hold | Downgrades | $29 → $9 | +506.06% | Jun 18, 2024 | 
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.